Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure
Use of EtCO2 and Prolonged Expiratory Maneuvers as a PaCO2 Predictor in Cases of Acute Hypercapnic Respiratory Failure
1 other identifier
observational
11
1 country
1
Brief Summary
In patients treated by Non invasive ventilation (NIV) due to acute hypercapnic respiratory failure, the interest of using the End-tidal Co2 measurement device "Capnostream" to evaluate PaCo2 and PaCo2 variations over time will be evaluated. Measurements will be done under normal expiration and under prolonged active and passive expiration maneuvers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 2, 2011
CompletedFirst Posted
Study publicly available on registry
December 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 16, 2013
May 1, 2013
4 months
December 2, 2011
May 15, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration
Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration
Sixty minutes
Eligibility Criteria
Intensive care unit patients equipped with arterial line requiring non invasive ventilation because of acute hypercapnic respiratory failure
You may qualify if:
- ICU patient equipped with arterial line
- NIV requirement
- Hypercapnia: PaCO2 \> 45mmhg
You may not qualify if:
- Severe hemodynamic instability
- Severe psychiatric disorders
- nasal lesions
- denied consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intensive care and burn unit, University Hospital of Lausanne
Lausanne, 1011, Switzerland
Related Publications (1)
Piquilloud L, Thevoz D, Jolliet P, Revelly JP. End-tidal carbon dioxide monitoring using a naso-buccal sensor is not appropriate to monitor capnia during non-invasive ventilation. Ann Intensive Care. 2015 Feb 12;5:2. doi: 10.1186/s13613-014-0042-8. eCollection 2015.
PMID: 25852962DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe Jolliet, Professor
University of Lausanne Hospitals
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 2, 2011
First Posted
December 9, 2011
Study Start
December 1, 2011
Primary Completion
April 1, 2012
Study Completion
December 1, 2012
Last Updated
May 16, 2013
Record last verified: 2013-05